The Body-Computer Interface
Within a decade, the doctor visit will be a distant memory.
AI will read your biochemistry and optimize your health in real time. Medicine shifts from reactive disease management to continuous healthcare that maximizes human potential and wellbeing. Prevention and enhancement become the default.
At Continuity, we're building the technology to enable autonomous healthcare and give people agency over their health.
AI Doctors and Infinite Healthcare Are Here
Consumer AI already handles 230 million health interactions per week—12x more than the 19 million weekly doctor visits in the United States. People rely on it to answer health questions, interpret labs, and autonomously refill prescriptions.
AI is rapidly closing the gap with and, in many cases, surpassing the best clinicians across diagnostics, treatment planning, and longitudinal reasoning.
Soon, the most capable doctor on Earth will be AI. Infinitely available, nearly free, more knowledgeable than any human, with perfect recall of your entire health history. Everyone will have their own AI doctor, and it will deliver the majority of care.
But one problem persists, even with superhuman intelligence.
The Intelligence Paradox
Train the most capable AI on every scientific paper, clinical trial, and patient record ever produced. It still won't know what is happening inside your body right now.
Your health is your biochemistry: thousands of molecules inside your body that are in constant flux—hormones, proteins, metabolites, peptides, and more. Every symptom, every disease, every sensation is a biochemical event.
That's why over 70% of medical decisions hinge on lab data.
This year, you will spend about 45 minutes with your doctor. This leaves over 500,000 minutes of biochemistry completely unseen. In that time, your body will undergo hundreds of thousands of changes across thousands of biomarkers.
Your biochemistry fluctuates massively, even within just a single day. Redrawn from Licinio et al., 1998
Look at the graphs. Which time point would you pick to test? What would it tell you?
Your annual lab test captures a single, random frame of a year-long movie.
Most measurements only become meaningful over time: their baseline, variability, rhythm, and transient events are the information. Measure someone's heart rate once and it tells you almost nothing about their cardiac health. A single snapshot strips all the context away. The same applies to nearly every biochemical signal: hormones, metabolites, inflammatory markers, and more.
Seventy years ago, physicists proved that capturing a dynamic signal requires sampling twice as fast as the signal change you’re trying to observe. No amount of intelligence can overcome this "speed limit" of information, called the Nyquist rate.
Healthcare's bottleneck is moving from intelligence to observability.
AI Needs a Nervous System
AI is a brain without a body. It can reason, but it can't sense.
Every single lab data point requires a patient to travel to a facility, trained clinicians to collect and process samples, and days or weeks of waiting for results. We can't fix this by running more tests. Our infrastructure doesn't scale and each test provides only a snapshot. Capturing biochemical dynamics would overwhelm both patients and the healthcare system, including the physicians trying to interpret the data.
AI doesn't have these constraints. It scales infinitely, runs around the clock, and can interpret vast amounts of multi-dimensional data no human could process.
Intelligence is rapidly commoditizing. Real-time biochemical data is not. This has to change.
AI needs a nervous system: a way to sense your biochemistry in real-time, without relying on centralized laboratories and trained clinicians.
That interface doesn’t exist yet. Physicians dreamed of it since the 1960s, when they saw the tricorder in Star Trek. Qualcomm spent millions trying to build one. Many others have tried. Everyone failed.
This is a genuinely hard problem. We started Continuity to solve it.
Continuity: The Nervous System for Health AI
While everyone is racing to build a better brain, we're building the nervous system.
At Continuity, we're building a body-computer interface that reads your biochemistry in real time and streams it to AI, giving you full agency over your health.
Our team built advanced biosensors at MIT, Caltech, Google X, Medtronic, Biolinq, and Seer—from chips profiling thousands of proteins to continuous biosensors.
Why Now: The Convergence of Two Platforms
The technology that unlocked real-time genome sequencing can now read the rest of your biochemistry. We've reprogrammed nanopore technology for highly parallelized, real-time reading of hormones, proteins, metabolites, and other biomarkers. Previous approaches required custom signal generation mechanisms for each biomarker. Ours uses one universal mechanism across all of them.
Recent AI models and autonomous high-throughput lab systems can now design, predict, and validate novel sensing elements for new biomarkers, and continue to improve rapidly. Our platform reduces the constraints for each element, allowing AI to move through cycles even faster. What used to take years now takes weeks.
We are early. The path ahead is long and there are many ways this could still fail. But the in-vitro data supports our approach, and our first human test was successful.
Closing the Loop
Medicine has been chasing closed-loop biological control for decades. Real-time biochemical data makes it possible.
Sense, decide, act. Without a human in the loop.
In 1999, it worked. Once. The continuous glucose monitor (CGM) put diabetes management on autopilot: sense glucose, decide the dose, deliver insulin in real time. That was 27 years ago. Today, it's still all we got because CGM technology is limited to that one molecule. The rest of human biochemistry—hormones, proteins, peptides, metabolites, and more—has remained unreadable in real time, locked behind lab visits and several days of waiting.
At Continuity, we're building the platform that reads your biochemistry in real time. Every lever that affects your health—therapeutics, nutrition, supplements, habits, environment—becomes observable and optimizable. Several peptide companies have shown interest in building closed loops on our platform. But peptides are just one loop. There will be thousands.
What This Looks Like (If Everything Goes Right)
You wake up energized. Your AI detected an overnight cortisol spike and adjusted your environment and wake time to reset your circadian rhythm.
After your morning run, it flags elevated inflammation and adjusts your nutrition, training, and peptide dose for enhanced recovery. Lunch shows up at your door, planned based on your biomarkers.
One Tuesday afternoon, your AI detects the immune signature of a brewing infection and has medication delivered to your doorstep before you feel a thing. Week after week, it watches for silent biomarker drifts and acts before they can become diabetes, heart disease, or another preventable chronic condition.
No appointment. No waiting room. No delay. Just your biochemistry, read continuously, acted on in real time, thanks to AI and your body-computer interface.
The Atlas of Human Biochemistry
A body-computer interface generates an entirely new category of data: the world’s first continuous, multi-biomarker biochemistry data stream across populations.
Whoever captures this data at scale will power the era of autonomous health. Continuous data creates a flywheel: better data means better AI models, better models attract more users, and more users generate more data.
At the population level, this becomes a living atlas of human biochemistry: what biology actually looks like across time, demographics, and interventions. It reveals relationships between biomarkers and disease, replaces population averages with individual baselines, and turns screening into passive detection. It compresses drug development cost and timelines and enables closed-loop delivery.
At Continuity, we're going to build this atlas and give humankind the ultimate form of agency: the ability to read, understand, and act on our health in real-time.
Stay in touch, follow us and join the waitlist at continuity.bio